Salem Investment Counselors’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8K Hold
300
﹤0.01% 882
2026
Q1
$10.8K Buy
+300
New +$7.77K ﹤0.01% 871
2025
Q4
Sell
-300
Closed -$5.47K 529
2025
Q3
$5.47K Hold
300
﹤0.01% 969
2025
Q2
$4.73K Hold
300
﹤0.01% 950
2025
Q1
$3.8K Hold
300
﹤0.01% 961
2024
Q4
$6.61K Hold
300
﹤0.01% 884
2024
Q3
$5.35K Hold
300
﹤0.01% 923
2024
Q2
$4.82K Hold
300
﹤0.01% 929
2024
Q1
$4.46K Hold
300
﹤0.01% 941
2023
Q4
$5.36K Hold
300
﹤0.01% 897
2023
Q3
$5.73K Hold
300
﹤0.01% 876
2023
Q2
$4.76K Hold
300
﹤0.01% 921
2023
Q1
$5.21K Hold
300
﹤0.01% 906
2022
Q4
$5.06K Hold
300
﹤0.01% 879
2022
Q3
$4K Hold
300
﹤0.01% 881
2022
Q2
$3K Hold
300
﹤0.01% 929
2022
Q1
$4K Buy
+300
New +$4.42K ﹤0.01% 862

Other funds holding CLMT

Salem Investment Counselors's CLMT Position: Q2 2026 in Review

Salem Investment Counselors held its Calumet Specialty Products (CLMT) position steady in Q2 2026 at 300 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #882.

Salem Investment Counselors first reported a position in CLMT in Q1 2022 and has held it in 17 quarters since. 27 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Salem Investment Counselors held 300 shares of Calumet Specialty Products worth $10.8K as of Q2 2026.
  • Salem Investment Counselors left its Calumet Specialty Products share count unchanged in Q2 2026.
  • Calumet Specialty Products made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #882 holding.
  • Salem Investment Counselors first reported a position in Calumet Specialty Products in Q1 2022 and has held it in 17 quarters since.
  • 27 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.